IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley ConferenceMarketBeat • 09/20/26
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm DetectionBusiness Wire • 09/17/26
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow IntelligenceBusiness Wire • 09/16/26
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of StockThe Motley Fool • 09/10/26
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/03/26
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare ConferenceBusiness Wire • 08/31/26
Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?Zacks Investment Research • 08/31/26
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?Zacks Investment Research • 08/21/26
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins ImproveZacks Investment Research • 08/20/26
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?Zacks Investment Research • 08/19/26
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer TestsMarketBeat • 08/14/26
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP TestBusiness Wire • 08/11/26
IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-MarketZacks Investment Research • 08/04/26